Minerva Neurosciences, Inc. (NERV)

Minerva Neurosciences Statistics

Total Valuation

NERV has a market cap or net worth of $10.98 million. The enterprise value is $49.62 million.

Market Cap	10.98M
Enterprise Value	49.62M

Important Dates

The next estimated earnings date is Wednesday, April 30, 2025, before market open.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	n/a

Share Statistics

NERV has 6.99 million shares outstanding. The number of shares has increased by 16.41% in one year.

Current Share Class	6.99M
Shares Outstanding	6.99M
Shares Change (YoY)	+16.41%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	4.02%
Owned by Institutions (%)	30.12%
Float	5.44M

Valuation Ratios

The trailing PE ratio is 8.26.

PE Ratio	8.26
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	-0.43
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	34.48
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.85

Current Ratio	7.85
Quick Ratio	7.53
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.79

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-29.04%
Return on Invested Capital (ROIC)	-31.08%
Return on Capital Employed (ROCE)	-63.69%
Revenue Per Employee	n/a
Profits Per Employee	$179,858
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.93% in the last 52 weeks. The beta is 0.09, so NERV's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	-43.93%
50-Day Moving Average	2.08
200-Day Moving Average	2.56
Relative Strength Index (RSI)	31.33
Average Volume (20 Days)	40,987

Short Selling Information

The latest short interest is 42,036, so 0.60% of the outstanding shares have been sold short.

Short Interest	42,036
Short Previous Month	20,897
Short % of Shares Out	0.60%
Short % of Float	0.77%
Short Ratio (days to cover)	0.69

Income Statement

Revenue	n/a
Gross Profit	-11.90M
Operating Income	-21.85M
Pretax Income	-33.65M
Net Income	1.44M
EBITDA	-21.84M
EBIT	-21.85M
Earnings Per Share (EPS)	$0.19

Balance Sheet

The company has $21.36 million in cash and $60.00 million in debt, giving a net cash position of -$38.64 million or -$5.52 per share.

Cash & Cash Equivalents	21.36M
Total Debt	60.00M
Net Cash	-38.64M
Net Cash Per Share	-$5.52
Equity (Book Value)	-25.69M
Book Value Per Share	-3.67
Working Capital	19.43M

Cash Flow

Operating Cash Flow	-19.55M
Capital Expenditures	n/a
Free Cash Flow	-19.55M
FCF Per Share	-$2.80

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NERV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.41%
Shareholder Yield	-16.41%
Earnings Yield	13.10%
FCF Yield	-178.06%

Analyst Forecast

The average price target for NERV is $5.00, which is 218.47% higher than the current price. The consensus rating is "Hold".

Price Target	$5.00
Price Target Difference	218.47%
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	87.53%

Stock Splits

The last stock split was on June 21, 2022. It was a reverse split with a ratio of 0.125:1.

Last Split Date	Jun 21, 2022
Split Type	Reverse
Split Ratio	0.125:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2